Stay updated on BI 695500 Clinical Trial in RA: Efficacy, PK, Safety

Sign up to get notified when there's something new on the BI 695500 Clinical Trial in RA: Efficacy, PK, Safety page.
Latest website image capture
Clouds background image

Latest updates to the BI 695500 Clinical Trial in RA: Efficacy, PK, Safety page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the efficacy or pharmacokinetics of BI 695500 compared to rituximab in patients with moderately to severely active Rheumatoid Arthritis.
    Difference
    0.1%
    Check dated 2024-06-06T14:45:54.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying requirements such as age, health condition, and prior treatments, along with inclusion and exclusion criteria for the study.
    Difference
    37%
    Check dated 2024-05-22T21:27:36.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-04-30T22:34:54.000Z thumbnail image

Stay in the know with updates to BI 695500 Clinical Trial in RA: Efficacy, PK, Safety

Enter your email address, and we'll notify you when there's something new on the BI 695500 Clinical Trial in RA: Efficacy, PK, Safety page.